RhumbLine Advisers’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.62M | Sell |
316,935
-47,086
| -13% | -$454K | ﹤0.01% | 1510 |
|
|
2026
Q1 | $2.7M | Buy |
364,021
+6,765
| +2% | +$71.2K | ﹤0.01% | 1706 |
|
|
2025
Q4 | $4.2M | Sell |
357,256
-25,399
| -7% | -$274K | ﹤0.01% | 1485 |
|
|
2025
Q3 | $2.95M | Sell |
382,655
-5,750
| -1% | -$40.3K | ﹤0.01% | 1698 |
|
|
2025
Q2 | $2.84M | Buy |
388,405
+21,816
| +6% | +$176K | ﹤0.01% | 1691 |
|
|
2025
Q1 | $3.48M | Sell |
366,589
-22,414
| -6% | -$280K | ﹤0.01% | 1538 |
|
|
2024
Q4 | $6.41M | Buy |
389,003
+9,098
| +2% | +$141K | 0.01% | 1296 |
|
|
2024
Q3 | $5.6M | Sell |
379,905
-2,431
| -0.6% | -$38K | 0.01% | 1368 |
|
|
2024
Q2 | $5.3M | Sell |
382,336
-3,297
| -0.9% | -$46.7K | 0.01% | 1365 |
|
|
2024
Q1 | $6.06M | Buy |
385,633
+694
| +0.2% | +$10.7K | 0.01% | 1314 |
|
|
2023
Q4 | $6.23M | Sell |
384,939
-25,446
| -6% | -$416K | 0.01% | 1281 |
|
|
2023
Q3 | $5.05M | Buy |
410,385
+749
| +0.2% | +$11.1K | 0.01% | 1337 |
|
|
2023
Q2 | $6.58M | Sell |
409,636
-8,722
| -2% | -$144K | 0.01% | 1221 |
|
|
2023
Q1 | $7.28M | Buy |
418,358
+12,582
| +3% | +$179K | 0.01% | 1125 |
|
|
2022
Q4 | $3.75M | Buy |
405,776
+29,628
| +8% | +$276K | 0.01% | 1445 |
|
|
2022
Q3 | $3.24M | Buy |
376,148
+16,812
| +5% | +$167K | ﹤0.01% | 1492 |
|
|
2022
Q2 | $2.93M | Buy |
359,336
+57,275
| +19% | +$547K | ﹤0.01% | 1553 |
|
|
2022
Q1 | $3.67M | Buy |
302,061
+19,588
| +7% | +$412K | ﹤0.01% | 1502 |
|
|
2021
Q4 | $9.64M | Buy |
282,473
+9,103
| +3% | +$356K | 0.01% | 1004 |
|
|
2021
Q3 | $13.2M | Sell |
273,370
-39,696
| -13% | -$1.84M | 0.02% | 806 |
|
|
2021
Q2 | $14.1M | Sell |
313,066
-1,056
| -0.3% | -$46.8K | 0.02% | 801 |
|
|
2021
Q1 | $15.2M | Buy |
314,122
+13,179
| +4% | +$686K | 0.02% | 739 |
|
|
2020
Q4 | $16.2M | Buy |
300,943
+9,630
| +3% | +$435K | 0.02% | 643 |
|
|
2020
Q3 | $10.7M | Sell |
291,313
-33,177
| -10% | -$1.23M | 0.02% | 735 |
|
|
2020
Q2 | $10.1M | Buy |
324,490
+3,474
| +1% | +$96.3K | 0.02% | 769 |
|
|
2020
Q1 | $8.86M | Buy |
321,016
+5,003
| +2% | +$150K | 0.02% | 712 |
|
|
2019
Q4 | $9.24M | Buy |
316,013
+19,861
| +7% | +$473K | 0.02% | 878 |
|
|
2019
Q3 | $5.66M | Buy |
296,152
+15,438
| +5% | +$362K | 0.01% | 1115 |
|
|
2019
Q2 | $6.16M | Buy |
280,714
+31,116
| +12% | +$683K | 0.01% | 1083 |
|
|
2019
Q1 | $5.11M | Buy |
249,598
+163,698
| +191% | +$2.84M | 0.01% | 1165 |
|
|
2018
Q4 | $1.08M | Buy |
85,900
+31,639
| +58% | +$472K | ﹤0.01% | 1962 |
|
|
2018
Q3 | $833K | Sell |
54,261
-928
| -2% | -$12.8K | ﹤0.01% | 2080 |
|
|
2018
Q2 | $724K | Buy |
55,189
+3,144
| +6% | +$34.6K | ﹤0.01% | 2148 |
|
|
2018
Q1 | $425K | Sell |
52,045
-930
| -2% | -$7.53K | ﹤0.01% | 2278 |
|
|
2017
Q4 | $469K | Sell |
52,975
-9,400
| -15% | -$86.7K | ﹤0.01% | 2255 |
|
|
2017
Q3 | $694K | Buy |
62,375
+875
| +1% | +$8.52K | ﹤0.01% | 2160 |
|
|
2017
Q2 | $551K | Buy |
61,500
+2,135
| +4% | +$16.9K | ﹤0.01% | 2242 |
|
|
2017
Q1 | $468K | Buy |
59,365
+1,674
| +3% | +$13.6K | ﹤0.01% | 2280 |
|
|
2016
Q4 | $494K | Buy |
57,691
+4,657
| +9% | +$39.9K | ﹤0.01% | 2231 |
|
|
2016
Q3 | $436K | Buy |
53,034
+1,499
| +3% | +$12.6K | ﹤0.01% | 2281 |
|
|
2016
Q2 | $414K | Buy |
51,535
+1,740
| +3% | +$13.9K | ﹤0.01% | 2328 |
|
|
2016
Q1 | $336K | Buy |
49,795
+465
| +0.9% | +$3.06K | ﹤0.01% | 2470 |
|
|
2015
Q4 | $388K | Buy |
49,330
+4,975
| +11% | +$36.4K | ﹤0.01% | 2409 |
|
|
2015
Q3 | $254K | Buy |
44,355
+1,765
| +4% | +$10.9K | ﹤0.01% | 2650 |
|
|
2015
Q2 | $230K | Buy |
+42,590
| New | +$220K | ﹤0.01% | 2808 |
|
|
2014
Q2 | – | Sell |
-26,877
| Closed | -$93K | – | 3048 |
|
|
2014
Q1 | $93K | Sell |
26,877
-1,600
| -6% | -$6K | ﹤0.01% | 2930 |
|
|
2013
Q4 | $103K | Hold |
28,477
| – | – | ﹤0.01% | 2953 |
|
|
2013
Q3 | $85K | Sell |
28,477
-323
| -1% | -$910 | ﹤0.01% | 2946 |
|
|
2013
Q2 | $115K | Buy |
+28,800
| New | +$110K | ﹤0.01% | 3212 |
|
Other funds holding NEO
FLAM
GF
NAMI
B
RhumbLine Advisers's NEO Position: Q2 2026 in Review
RhumbLine Advisers reduced its NeoGenomics (NEO) stake by 13% in Q2 2026, selling an estimated $454K and leaving 316,935 shares worth $4.62M. The position accounts for ﹤0.01% of the portfolio, ranked #1510.
RhumbLine Advisers first reported a position in NEO in Q2 2013 and has held it in 49 quarters since. The position peaked at $16.2M in Q4 2020. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- RhumbLine Advisers held 316,935 shares of NeoGenomics worth $4.62M as of Q2 2026.
- RhumbLine Advisers sold 47,086 NeoGenomics shares in Q2 2026, an estimated $454K.
- NeoGenomics made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #1510 holding.
- RhumbLine Advisers first reported a position in NeoGenomics in Q2 2013 and has held it in 49 quarters since.
- RhumbLine Advisers's NeoGenomics position peaked at $16.2M in Q4 2020.
- 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.